Tefibazumab: Difference between revisions
Content deleted Content added
remove 'image = {{PAGENAME}}.png' from drugbox, see template talk:drugbox using AWB |
m drugbox -> drugbox-mab |
||
| Line 1: | Line 1: | ||
{{drugbox | |
{{drugbox-mab | |
||
| |
| image = |
||
| source = Humanized |
|||
| image = |
|||
| target = |
|||
| CAS_number = |
| CAS_number = |
||
| ATC_prefix = |
| ATC_prefix = |
||
Revision as of 05:56, 12 March 2007
Tefibazumab (marketed under the brand name Aurexis®) is a humanized monoclonal antibody and which it is used to treat bacterial infections.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |